To further facilitate the clinical translation of this combination approach, nanodrug delivery strategy was applied in this study to enhance the drug accumulation at tumor sites while reducing unwanted adverse effects through enhanced permeability and retention (EPR) effect.[17] A novel polymersome was developed to co‐encapsulate EIPA into the hydrophilic core and BTZ in the hydrophobic membrane bilayer (Figure6A). This evidence concerns the gene CASC3 and neoplasm.